Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentamidine in advanced pancreatic cancer
NCT00810953Phase 2Completed
- Sponsor
- Oncozyme Pharma
- Start
- Jan 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pentamidine in pancreatic cancer (PC), sponsored by Oncozyme Pharma. Started Jan 2009; status: completed.
02
Drugs
pentamidine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00810953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00810953.